Burgdorf Osceola (study sponsor) must not be contacted in regards to the results of this study or in any other manner that may serve to identify any of the study participants. In this way there shall be no contact in regards to the Pharmasan Laboratories iSpot LymeTM, the Quest diagnostics ELISA, or the Quest diagnostics western blot results. If such contact occurs this could jeopardize the sample blinding process and that patient will have to be removed from the study population. A secondary consequence would be that the HCP forfeits their compensation for that patient. For other inquiries and notices, the study coordinator may be contacted by written or electronic mail.Burgdorf Osceola, L.L.C.